Johns Hopkins ABX GuideBrand Names

Varicella Zoster- Hyperimmune globulin

Paul A. Pham, Pharm.D., Edina Avdic, Pharm.D.
Varicella Zoster- Hyperimmune globulin is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • VZV post-exposure prophylaxis in high risk individuals:
    • Immunocompromised children and adults
    • Newborns of mothers with varicella around the time of delivery
    • Premature infants
    • Infants < 1 year of age
    • Adults without evidence of the immunity
    • Pregnant women
  • ACIP and AAP recommends administration of VariZIG as soon as possible after exposure and within 10 days[1]
    • The ACIP and AAP recommendations for post-exposure prophylaxis:
      • Immunocompromised patients without evidence of immunity.
      • Newborn infants whose mothers have signs and symptoms of varicella around the time of delivery (i.e., 5 days before to 2 days after delivery).
      • Hospitalized premature infants born at ≥ 28 weeks of gestation whose mothers do not have evidence of immunity to varicella.
      • Hospitalized premature infants born at < 28 weeks of gestation or who weigh ≤1000 g at birth, regardless of their mother’s evidence of immunity to varicella.
      • Pregnant women without evidence of immunity.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: April 5, 2016